PRLD Prelude Therapeutics Incorporated
Healthcare$4.27-1.39%ClosedMarket Cap: $243.1M
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
7
Dispositions
1
Buy/Sell Ratio
7.00
Net Shares
+7,882,882
Shares Acquired
9,289,882
Shares Disposed
1,407,000
Total Bought ($)
$6.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon May 04 | Morris Charles Q | officer: Chief Medical Officer | Sell | 450,000 | $4.70 | 450,000 |
| Tue Apr 28 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Sell | 1,407,000 | $0.00 | 6,475,882 |
| Tue Apr 28 | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Sell | 0 | $0.00 | 7,882,882 |
| Thu Apr 23 | ORBIMED ADVISORS LLC | director, 10 percent owner: | Buy | 1,689,189 | $4.44 | 11,808,945 |
| Thu Apr 23 | ORBIMED ADVISORS LLC | director, 10 percent owner: | Buy | 1,126,126 | $4.44 | 1,126,126 |
| Thu Apr 23 | Bonita David P | director, 10 percent owner: | Buy | 1,689,189 | $4.44 | 11,808,945 |
| Thu Apr 23 | Bonita David P | director, 10 percent owner: | Buy | 1,126,126 | $4.44 | 1,126,126 |
| Wed Apr 22 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | Buy | 2,137,651 | $0.00 | 20,105,994 |
| Wed Apr 22 | BAKER BROS. ADVISORS LP | director, 10 percent owner: | Buy | 114,601 | $0.00 | 1,678,273 |
| Wed Apr 15 | Morris Charles Q | Sell | 0 | $0.00 | 0 | |
| Thu Mar 19 | Brusky Sean P. | officer: Chief Business Officer | Sell | 275,000 | $0.00 | 0 |
| Thu Mar 19 | Brusky Sean P. | officer: Chief Business Officer | Sell | 0 | $0.00 | 100,000 |
| Thu Feb 05 | Vaddi Krishna | director, officer: CEO | Sell | 837,000 | $2.30 | 837,000 |
| Thu Feb 05 | Scherle Peggy | officer: Chief Scientific Officer | Sell | 230,000 | $2.30 | 230,000 |
| Thu Feb 05 | Lim Bryant David | officer: CLO, CFO, Corp Sec. | Sell | 275,000 | $2.30 | 275,000 |